INTRODUCTION
Congenital hypoplastic anemia (the Diamond-Blackfan Syndrome) is considered to be an isolated failure of erythropoiesis presenting in the first months of life as anemia and bone marrow erythroid hypoplasia, Received for publication 26 January 1980 and in revised form 6 May 1982. without involvement of the lymphoid or myeloid cell lines (1) . However, although mild leukopenia has been reported in some patients (2) , abnormalities of lymphocyte number and function have not been described previously. Our recent investigations of a patient with congenital hypoplastic anemia and overt immunodeficiency (3) led us to evaluate immunologic function in all of our patients with the Diamond-Blackfan Syndrome.
In this study, we have examined immunologic function concomitantly with investigations of erythropoiesis in five patients with congenital hypoplastic anemia. Our investigations have revealed impaired lymphocyte proliferation and suppressor cell function, indicating that in our patients with this condition, the defect is not restricted to the erythroid series, but may extend to involve the immune system.
METHODS Patients
Five patients with proven Diamond-Blackfan Syndrome were included in the study. Their ages at study ranged from 2 to 20 yr; however, they had all presented within the first year of life, with a profound hypoproliferative anemia shown on bone marrow aspiration to involve solely the erythroid series. Their hemoglobin concentrations at study ranged from 11 .0 to 13.4 g/dl. Three of the patients, A.F., J.St., and S.W., have been off prednisone therapy for 1, 3 , and 17 yr, respectively. Two patients were still on prednisone at the time of study; patient E.D., 2.5 mg/wk and patient J.Sc., 5 mg on alternate days.
Three of the patients had never received blood transfusions, while two had received up to three transfusions early in the course of their disease (patients J.Sc. and J.St.). None of the patients had shown any particular susceptibility to infections. No patients had clinical evidence of autoimmune disorders, and fluorescent antibody screening for antinuclear, smooth muscle, mitochondrial, and parietal cell antibodies was negative. None of the patients showed evidence of adenosine deaminase or nucleoside phosphorylase deficiencies, as determined by appropriate enzyme screening (4) . There were no family histories of either hematologic or immunologic disorders. All patients were studied on at least two occasions from 20 to 21 mo apart. Following incubation, 100,000 cells, washed three times with PBS, and irradiated at 2,500 rad, were added to a one-way MLR consisting of 100,000 normal responder cells and 100,000 irradiaied (2,500 rad) allogeneic normal stimulator cells. Adherent cell suppressor system (8) . In this system, the effect of 800,000 fresh irradiated (2,500 rad) patient mononuclear cells as stimulators in a one-way MLR to 100,000 normal responder cells is compared with the effect of 200,000 fresh irradiated patient cells acting as stimulators in an identical system. The fourfold increase in stimulator population results in a decreased [3Hjthymidine incorporation in normal individuals, which has been shown to be due to the suppressive effect of an adherent, radioresistant mononuclear cell.
Mononuclear cell separation
Native, or natural suppressor system. In this system, the effects of fresh irradiated (2,500 rad) patient mononuclear cells upon a one-way MLR is compared with the effect of fresh irradiated allogeneic normal cells in an identical MLR. Briefly, 100,000 fresh irradiated patient mononuclear cells were incubated with 100,000 normal responder cells (N1) (10) . After 7 d in culture, erythroid colonies (CFU-E) were enumerated following staining with benzidine hydrochloride; eight or more cells in a cluster were scored as a colony. The effect of patient peripheral blood mononuclear cells and cell subpopulations upon syngeneic or allogeneic normal bone marrow erythroid colony growth was also studied in all five patients, by mixing the cell populations together before addition to the culture system. In all studies, 1 X 105 peripheral blood mononuclear cells were co-cultured with 2 X 105 bone marrow cells.
RESULTS
Lymphocyte enumeration. In Table I , the total leukocyte and differential counts are detailed. No consistent significant abnormalities in the total leukocyte counts, the total lymphocyte counts, or the total T lymphocyte counts (as enumerated by sheep erythrocyte rosetting) were found in any of our five patients. Total leukocyte counts were low on at least one occasion in two patients (2,800 and 3,900/mm3); however, both of these individuals had normal total leukocytes at the other time tested. Absolute lymphocyte counts were low in three instances; again, this was not a constant finding. Similarly, T lymphocyte percentages were low in three when initially tested, but a repeat determination showed normal values. However a striking finding was demonstrated by the use of monoclonal anti T cell antibodies. Low percentages of OKT3 reactive cells were noted in four of the five patients, despite Table II, proliferative responses to mitogens (PHA, Con A, PWM) and allogeneic cells were essentially normal.
Suppression of lymphocyte proliferation (Table  III) . In the prostaglandin-mediated suppressor assay, the presence of a suppressor of PHA-induced lymphoproliferation is demonstrated indirectly by blocking the suppressor with indomethacin. Thus, the increased PHA response in the presence of indomethacin reflects abolition of the suppressor. This suppressor cell is usually demonstrated in normal peripheral blood mononuclear cells, with indomethacin producing an Erythroid colony cultures. Culture of the patients' bone marrow mononuclear cells in the presence of human urinary erythropoietin produced markedly reduced number of CFU-E colonies after 7 d in culture (10-40% of simultaneously cultured normal bone marrows) (Table V) .
Upon co-culture of patient peripheral blood mononuclear cells and cell subpopulations (T enriched and T depleted) with normal bone marrow, suppressive effects upon normal bone marrow erythroid colony growth were demonstrated only in patient E.D. The results of studies in this patient are summarized in Table VI . Normal laboratory values 27±9.5 (5 normals) 26±6.8 (7 normals) 1 X 105 normal or patient peripheral blood mononuclear cells were cultured in quadruplicate with 0.3 jig PHA over a feeder layer of 0.5% agar containing either no cells or 5 X 105 irradiated peripheral blood mononuclear cells. Colonies were enumerated after 6 d in culture. As compared with normal values for our laboratory, patient E.D. grew statistically fewer colonies when cultured without feeder cells or with autologous feeder cells (P < 0.001). However, colony growth was significantly increased (P < 0.001) in the presence of allogeneic normal feeder cells. Further, his own cells, when serving as feeder cells, significantly suppressed normal T lymphocyte colony growth (P < 0.001).
In patient S.W., CFU-TL were unaltered by the presence or absence of autologous or allogeneic normal feeder cells. Further, her cells, serving as feeder cells, did not suppress normal CFU-TL growth. CFU-TL values represent mean±1 SD of quadruplicate cultures.
Lymphocyte Dysfunction in Congenital Hypoplastic Anemia 2 X 105 normal bone marrow mononuclear cells were grown in methylcellulose cultures containing 2 U human urinary erythropoietin. Each patient was studied simultaneously with a normal control bone marrow culture. CFU-E values represent means of duplicate cultures. While normal CFU-E growth varied widely (from 27 to 91 mean colonies), the patient CFU-E growth obtained was between 10 and 40% of the simultaneously studied controls.
DISCUSSION
We have demonstrated lymphocyte abnormalities in patients whose primary disorder involves erythropoiesis. Obviously, the lymphocyte abnormalities observed are not of sufficient magnitude to cause unusual susceptibility to infections in these patients. Low numbers of T lymphocytes, as measured by OKT3 monoclonal antibodies, were found in three patients. A striking abnormality, however, was the reduction in the ratio of T helper to T suppressor cells (OKT4:OKT8). In our laboratory, as well as in others, this ratio is normally 2:1. However, in four of our patients, this ratio approached unity. Functional assessments revealed further abnormalities. All four patients tested demonstrated a complete inability to generate Con A-induced suppressor cells; these suppressor cells have been shown to be T lymphocytes (11) and are present in normal individuals (8) . Although absence of this capability has previously been reported in systemic lupus erythematosus (11) , no evidence of any autoimmune disturbance was found in any of our patients. Two of the patients displayed consistently impaired or absent prostaglandin-induced suppression. The finding of altered suppressor cell functions in the face of a relatively high percentage of OKT8+ T suppressor cells highlights the subtle nature of the lymphocyte abnormalities. The necessity of correlating counting assays with functional tests is illustrated by these results. Another possibility is that the OKT distribution reflects a modest helper inadequacy. The exact reasons for this abnormal ratio of OKT4:OKT8 remains unknown. It is of interest to note, however, that in the same four patients with abnormal OKT4:OKT8 ratios, there was also an inability to generate Con A-induced suppressor cells.
These results could suggest (a) that there is a regulatory defect involving suppressor mechanisms or a relative helper deficiency, or (b) that there is an intrinsic proliferative defect. Additional studies, described below, revealed that each of these patterns of immunologic dysfunction appear to exist in our patients.
Patient E.D. seemed to show excessive suppression mediated by two cell lines. Specifically, he possessed In our three remaining patients who also showed some impairment of lymphocyte function we were however unable to demonstrate any excessive suppressor activities directed against either lymphocyte proliferation or erythropoiesis. This finding is more suggestive of an intrinsic cellular defect rather than a disturbance of cell regulation as demonstrated by patient E.D. An alternative explanation to be considered is that these four patients lack necessary helper cells required for normal erythropoiesis and lymphopoiesis. Nathan et al. (17) have demonstrated that either syngeneic or allogeneic purified T lymphocytes will stimulate erythroid colony growth (BFU-E) by peripheral blood "null" cells, although they could not prove that such helper cells were an absolute requirement for erythropoiesis. In further studies, they have indicated that T helper function for erythropoiesis was not deficient in their patients with congenital hypoplastic anemia (14) . However, it is presently unclear whether T helper cells are even required for normal bone marrow, rather than peripheral blood, erythroid colony growth (18) . In our own patients, addition of normal peripheral blood mononuclear cells to patients' bone marrows in erythroid cultures failed uniformly to improve the poor erythroid colony growth of the patients, arguing against a helper cell defect in our patients, and supportive of an intrinsic proliferative defect.
It should also be pointed out that the assay systems used may not be capable of detecting excessive suppressor mechanisms; if such suppression were genetically restricted, then with respect to erythropoiesis, coculture of patient peripheral blood mononuclear cells with allogeneic normal bone marrow would not produce suppression of erythroid colony growth of the allogeneic marrow. To date, there is no evidence of genetically restricted cell-mediated suppressor mechanisms operant in either normal or deranged states of erythroid or lymphoid function in man. However, genetic restriction of virus-induced cell-mediated cytotoxicity has been implicated as a pathogenetic mechanism in some patients with aplastic anemia (19) . Extrapolation of this type of mechanism to congenital hypoplastic anemia remains highly speculative.
Hoffman et al. (12) have demonstrated cell-mediated suppression of normal bone marrow erythroid colony growth (CFU-E) by peripheral blood lymphocytes from some patients with congenital hypoplastic anemia. Similarly, Steinberg et al. (13) have shown that peripheral blood lymphocytes from patients with congenital hypoplastic anemia could inhibit the erythroid colony growth (BFU-E) of both normal and patients' peripheral blood. We have recently reported our studies in a patient with monocyte-mediated suppression of erythropoiesis in association with congenital hypoplastic anemia (3) . Other groups have been unable to demonstrate cell-mediated suppression of erythropoiesis in their patients with congenital hypoplastic anemia (14, 15) . We attribute the differences in findings by various investigators to a diversity of pathogenetic mechanisms in these patients.
Our data presented here indicate that in congenital hypoplastic anemia, pathogenetic mechanisms may include regulatory defects as well as intrinsic cellular defects, involving not only the erythroid cell series, but which are reflected in studies of the immune system.
